PR Newswire: news distribution, targeting and monitoring
Home Page > News Releases > Industry News > Frost & Sullivan: Indonesia continues to be one of the more attractive markets in ASEAN for foreign healthcare companies

Frost & Sullivan: Indonesia continues to be one of the more attractive markets in ASEAN for foreign healthcare companies

2014-06-28 18:00
Share with Twitter

JAKARTA, Indonesia, June 28, 2014 /PRNewswire/ -- Frost & Sullivan is optimistic on growth in Indonesia's Healthcare market, driven by various factors such as investments into Indonesia and growing availability of healthcare services and access in the country. As the ASEAN region grows, Indonesia with its 247 million population is one of the more attractive markets.

Mrs. Rhenu Bhuller, Senior Vice President, Healthcare Frost & Sullivan said that Asia-Pacific Healthcare expenditure per capita is expected to increase 4.8% across the region by 2018. Indonesia per capita expenditure is expected to increase from US$ 109 to US$ 237 in 2018, representing a year on year growth of close to 14%. The total of APAC healthcare spending is expected to grow from US$1.3tn to US$2.2tn in 2018 at a CAGR 10.5%, with ASEAN growing at 11%, she added.                

Mrs Bhuller also noted that Indonesia has one of the fastest growing private hospital sectors in the region. In addition, Indonesia's imports of medical equipment have been on the rise since 2004 indicating underlying domestic demand. While the growth has been uneven from year to year, contributed in some way due to currency fluctuations, the overall trend has been upwards.

Private Healthcare Services – Focus Growth Sector

Within the region, Indonesia and Philippines have the highest shortage of beds and are targets for hospital operators expansions. About 4.2 Million new beds will be needed over next decade to meet the healthcare demand in APAC; more than 40% of that is expected to come from private sector. Frost & Sullivan estimates that more than 35,000 new beds could be added in Indonesia by 2020. One of the larger challenges, however, is the lack of qualified human resources in the healthcare sector, raising a need for in house, as well as across country training programmes. The collaboration with foreign doctors can drive sharing of skills and expertise to local staff.

Favorable government policies, increasing disposable income, changing demographics and  increasing chronic disease burden will drive growth in private hospitals. There is a increasing trend of hospital consolidation in private sector in APAC. Several bigger hospital groups from within and outside of APAC are acquiring smaller hospitals in the region due to forecasted market potential. The private hospital market in Asia Pacific is expected to exceed USD 1 billion by 2017, a yearly growth rate of 17% from 2014. However, the track record of foreign investment in hospitals in Indonesia is relatively lower than other countries. Foreign activity has more been around real estate investment trusts acquiring the real estate asset for a hospital from a related party, but there is increasing local activity in hospital development as hospital groups look to expand beyond Jakarta, Bandung and Surabaya.

Another growth driver for this sector is medical tourism. Thailand, Singapore and Malaysia had 2.5 million medical tourists coming through in 2012. Governments in Malaysia and Singapore continue to set aggressive growth targets, and hospitals like Institut Jantung Negara, Malaysia's leading cardiac centre, have established initiatives to woo Indonesian patients.

Healthcare Industry - Business Opportunities, Indonesia, 2014-2018

Pharmaceuticals and Medical Devices 

Indonesia's pharmaceutical market is among the top three in terms of growth in ASEAN, and is forecasted to cross USD 10 billion in 2018. Indonesia also has the highest proportion of OTC sales in ASEAN, at 40% of the pharmaceutical market, indicating the propensity of Indonesian consumers towards self medication.

Mrs. Bhuller also said that the middle income local population are increasingly preferring branded generics to lower-cost unbranded drugs. This creates significant opportunities for companies manufacturing branded generics.

The medical devices market is forecasted to grow at 12.5% yearly from 2013 to 2018, and should cross USD 1 billion in 2018. Mrs. Bhuller said that business opportunities exist in surgical equipment, diagnostics and medical imaging equipment and diagnostics.

Future Outlook for Indonesia

Universal healthcare will generate demand in a new population group: by providing access, amongst those that never could have afforded it before. This will further drive demand of generic medication. Generics manufacturers will need to develop strategies to market its off patent generic products to the bottom of the pyramid to play the "high volume, low margin game"

Increase in healthcare spending: Public spending that has traditionally been very low, will have to increase to be able to achieve Universal healthcare by 2019.
Private healthcare services will have to address the huge gap in the healthcare infrastructure as Public hospitals alone will not be able to achieve it.
Different targeting strategies are important to meet gaps in various consumer segments, e.g. the growing middle income group.

Private Players will continue to expand to capture the affluent patient base:

Private hospitals will continue to expand to capture the substantial base of affluent medical tourists that travel to Singapore, Malaysia, Thailand for treatment. Indonesia is starting to promote medical tourism more strongly in areas like Bali with aesthetics treatment.

Source: Frost & Sullivan

Featured Video

Health Care/Hospital Recent Releases

Medical Equipment Recent Releases

Medical/Pharmaceuticals Recent Releases

Pharmaceuticals Recent Releases

Advanced Search
Search
  
  1. Products & Services
  2. News Releases
  3. Knowledge Center
  4. For Journalists & Media
  5. Multimedia Theater
  6. Contact Us